Economic evaluation of implementing a decentralised Hepatitis B virus diagnostic intervention under National Viral Hepatitis Control Programme in Tamil Nadu, South India

To assess the cost‐effectiveness of decentralised diagnostic programme for hepatitis B virus (HBV) implemented in Tamil Nadu, South India with specific focus on a selected key population at increased risk of HBV.

[1]  P. Malhotra.  Prevalence of Hepatitis B and Hepatitis C in Tertiary Care Center of Northeren India , 2020 .

[2]  H. Bekedam,et al.  Cost-Effectiveness of Therapeutic Use of Safety-Engineered Syringes in Healthcare Facilities in India , 2019, Applied Health Economics and Health Policy.

[3]  S. Prinja,et al.  Real-world cost-effectiveness of pan-genotypic Sofosbuvir-Velpatasvir combination versus genotype dependent directly acting anti-viral drugs for treatment of hepatitis C patients in the universal coverage scheme of Punjab state in India , 2019, PloS one.

[4]  H. D. de Melker,et al.  Cost-effectiveness of screening for chronic hepatitis B and C among migrant populations in a low endemic country , 2018, PloS one.

[5]  P. Abraham,et al.  Will an innovative connected AideSmart! app-based multiplex, point-of-care screening strategy for HIV and related coinfections affect timely quality antenatal screening of rural Indian women? Results from a cross-sectional study in India , 2018, Sexually Transmitted Infections.

[6]  R. Dhodapkar,et al.  The prevalence of occult hepatitis B infection among the blood donors in a tertiary care hospital, Puducherry , 2018, Indian journal of medical microbiology.

[7]  A. Cicchetti,et al.  Economic Evaluation of the Hepatitis C Virus Treatment Extension to Early-Stage Fibrosis Patients: Evidence from the PITER Real-World Cohort. , 2017, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[8]  Davey M. Smith,et al.  HIV, Hepatitis B Virus, and Hepatitis C Virus Prevalence Among High-Risk Populations in South India. , 2017, AIDS research and human retroviruses.

[9]  Y. Chawla,et al.  Cost of Intensive Care Treatment for Liver Disorders at Tertiary Care Level in India , 2017, PharmacoEconomics - Open.

[10]  G. Ray.  Current Scenario of Hepatitis B and Its Treatment in India , 2017, Journal of clinical and translational hepatology.

[11]  R. Aggarwal,et al.  Cost-effectiveness of hepatitis C treatment using generic direct-acting antivirals available in India , 2017, PloS one.

[12]  T. Hallett,et al.  Cost-effectiveness of community-based screening and treatment for chronic hepatitis B in The Gambia: an economic modelling analysis. , 2016, The Lancet. Global health.

[13]  S. Husain,et al.  Multiplex Reverse Transcriptase-PCR for Simultaneous Detection of Hepatitis B, C, and E Virus. , 2016, Journal of clinical and experimental hepatology.

[14]  Li Li,et al.  An economic analysis of adult hepatitis B vaccination in China. , 2015, Vaccine.

[15]  Ashish Kumar.  Current practices in management of hepatocellular carcinoma in India: results of an online survey. , 2014, Journal of Clinical and Experimental Hepatology.

[16]  Ajit Kumar,et al.  Hepatitis B and/or C co-infection in HIV infected patients: A study in a tertiary care centre from south India , 2013, The Indian journal of medical research.

[17]  V. Balraj,et al.  Evaluation of a programme for prevention of vertical transmission of hepatitis B in a rural block in southern India , 2013, The Indian journal of medical research.

[18]  S. Biswas,et al.  Performance and diagnostic usefulness of commercially available enzyme linked immunosorbent assay and rapid kits for detection of HIV, HBV and HCV in India , 2012, Virology Journal.

[19]  D. Celentano,et al.  The Emerging HIV Epidemic among Men Who have Sex with Men in Tamil Nadu, India: Geographic Diffusion and Bisexual Concurrency , 2010, AIDS and Behavior.

[20]  S. Thyagarajan,et al.  Coinfection of hepatitis B and hepatitis C virus in HIV-infected patients in south India. , 2007, World journal of gastroenterology.

[21]  M. Bayliss,et al.  Health assessment for chronic HCV infection , 1996, Digestive Diseases and Sciences.

[22]  A. Hamide,et al.  Co-infection with hepatitis C virus and human immunodeficiency virus among patients with sexually transmitted diseases in Pondicherry, South India. , 2003, Indian Journal of Pathology and Microbiology.

[23]  S. Asia,et al.  WORLD HEALTH ORGANIZATION REGIONAL OFFICE FOR , 2003 .

[24]  P. Abraham,et al.  Evaluation of an indigenously manufactured rapid immunochromatographic test for detection of HBsAg. , 2001, Indian journal of pathology & microbiology.

[25]  A. Oberoi,et al.  Evaluation of rapid kits for detection of HIV, HBsAg and HCV infections. , 2000, Indian journal of medical sciences.

[26]  N. Chandrasekaran,et al.  Relative prevalence of hepatitis B viral markers and hepatitis C virus antibodies (anti HCV) in Madurai, south India. , 2000, Indian journal of medical sciences.

[27]  P. Das,et al.  Hepatitis C Virus Prevalence among Blood Donors from South India , 2000, Vox Sanguinis.

[28]  H. Thomas,et al.  Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis , 1998, Hepatology.

[29]  G. Sridharan,et al.  Evaluation of two immunochromatographic assays in relation to `RAPID' Screening of HBsAG , 1998 .

[30]  R. Aggarwal,et al.  Prevention of hepatitis B infection: the appropriate strategy for India. , 1994, The National medical journal of India.

[31]  E. Schiff,et al.  Assessing health-related quality of life in chronic hepatitis C using the Sickness Impact Profile. , 1994, Clinical therapeutics.

[32]  F. Guidozzi,et al.  Should pregnant urban south African women be screened for hepatitis B? , 1993, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.